AR111166A1 - Uso intradialítico de nitrito de sodio - Google Patents

Uso intradialítico de nitrito de sodio

Info

Publication number
AR111166A1
AR111166A1 ARP180100529A ARP180100529A AR111166A1 AR 111166 A1 AR111166 A1 AR 111166A1 AR P180100529 A ARP180100529 A AR P180100529A AR P180100529 A ARP180100529 A AR P180100529A AR 111166 A1 AR111166 A1 AR 111166A1
Authority
AR
Argentina
Prior art keywords
dialysate
unenriched
nitrite
enriched
membrane
Prior art date
Application number
ARP180100529A
Other languages
English (en)
Spanish (es)
Inventor
Craig Sherman
Original Assignee
Hope Medical Entpr Inc Dba Hope Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hope Medical Entpr Inc Dba Hope Pharmaceuticals filed Critical Hope Medical Entpr Inc Dba Hope Pharmaceuticals
Publication of AR111166A1 publication Critical patent/AR111166A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A61M1/1656—Apparatus for preparing dialysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP180100529A 2017-03-08 2018-03-07 Uso intradialítico de nitrito de sodio AR111166A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762468857P 2017-03-08 2017-03-08

Publications (1)

Publication Number Publication Date
AR111166A1 true AR111166A1 (es) 2019-06-12

Family

ID=63445965

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180100529A AR111166A1 (es) 2017-03-08 2018-03-07 Uso intradialítico de nitrito de sodio

Country Status (15)

Country Link
US (5) US10328099B2 (https=)
EP (2) EP4406595A3 (https=)
JP (3) JP7314050B2 (https=)
KR (4) KR20250017763A (https=)
AR (1) AR111166A1 (https=)
AU (2) AU2018231016B2 (https=)
BR (1) BR112019018861A2 (https=)
CA (1) CA3055105A1 (https=)
ES (1) ES2986444T3 (https=)
IL (4) IL312092B2 (https=)
NZ (4) NZ797744A (https=)
PH (1) PH12019501950A1 (https=)
TW (3) TWI835595B (https=)
WO (1) WO2018165098A1 (https=)
ZA (3) ZA201905679B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019018861A2 (pt) * 2017-03-08 2023-10-10 Hope Medical Entpr Inc Dba Hope Pharmaceuticals Uso de nitrito de sódio, método para manter os níveis fisiológicos de nitrito, prevenir enfarte do miocárdio, prevenir morte súbita cardíaca, prevenir acidente vascular cerebral, doenças cardiovasculares, pressão alta, solução aquosa
IL268883B (en) 2017-03-08 2022-09-01 Hope Medical Entpr Inc Dba Hope Pharmaceuticals Intradialytic use of sodium thiosulfate
EP4005611B1 (en) * 2019-07-22 2025-11-26 School Juridical Person The Kitasato Institute Dialysis device
US20230149732A1 (en) * 2021-11-17 2023-05-18 Wake Forest University Health Sciences Combined nitrite and light treatment to prevent device thrombosis
CN120456938A (zh) 2022-12-16 2025-08-08 费森尤斯医疗保健控股公司 用于在透析中使用一氧化氮的系统和方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218900B1 (en) 1985-09-10 1992-01-22 Research Corporation Technologies, Inc. Osmotic agents for peritoneal dialysis
US6380163B1 (en) 1992-12-22 2002-04-30 Baxter International Inc. Peritoneal dialysis solutions with polypeptides
FI98538C (fi) 1993-10-20 1997-07-10 Enso Gutzeit Oy Menetelmä natriumhydroksidin valmistamiseksi valkolipeästä
US6306836B1 (en) 1994-01-21 2001-10-23 Baxter International Inc. Peritoneal dialysis solutions containing maltodextrins and amino acids
US6436969B1 (en) 1995-09-12 2002-08-20 Kansas University Medical Center Research Institute Inc. Dialysis solutions and methods
JP4882054B2 (ja) 2000-09-13 2012-02-22 独立行政法人科学技術振興機構 腹膜透析液およびその調製法
JP5564158B2 (ja) * 2003-07-09 2014-07-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 亜硝酸塩によって特定の心臓血管状態を処置する方法
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US20070154570A1 (en) * 2004-09-29 2007-07-05 Miller Christopher C Use of nitric oxide in the treatment and disinfection of biofilms
US7547637B2 (en) * 2005-06-21 2009-06-16 Intel Corporation Methods for patterning a semiconductor film
US20090304600A1 (en) 2008-06-09 2009-12-10 Anupkumar Shetty Intradialytic administration of sodium thiosulfate
US8568793B2 (en) 2009-02-11 2013-10-29 Hope Medical Enterprises, Inc. Sodium nitrite-containing pharmaceutical compositions
AU2010270605B2 (en) 2009-07-08 2014-07-31 Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals Sodium thiosulfate-containing pharmaceutical compositions
CA2844759A1 (en) * 2011-08-11 2013-02-14 Nathan S. Bryan Method of measuring and monitoring in vivo nitrite levels
WO2013112582A1 (en) 2012-01-23 2013-08-01 Santalis Pharmaceuticals Inc. Sandalwood oil and its uses related to clostridium infections
JP5486069B1 (ja) 2012-11-05 2014-05-07 旭 酒井 透析装置
US20140350097A1 (en) 2013-05-23 2014-11-27 Medinox,Inc. Treatment of hypotension associated with hemodialysis
JP6183832B2 (ja) * 2013-06-19 2017-08-23 扶桑薬品工業株式会社 酸化ストレス抑制型透析用剤およびその調製方法
BR112019018861A2 (pt) * 2017-03-08 2023-10-10 Hope Medical Entpr Inc Dba Hope Pharmaceuticals Uso de nitrito de sódio, método para manter os níveis fisiológicos de nitrito, prevenir enfarte do miocárdio, prevenir morte súbita cardíaca, prevenir acidente vascular cerebral, doenças cardiovasculares, pressão alta, solução aquosa

Also Published As

Publication number Publication date
TW202421096A (zh) 2024-06-01
US12011456B2 (en) 2024-06-18
AU2024203535A1 (en) 2024-06-20
TWI888012B (zh) 2025-06-21
KR20250017763A (ko) 2025-02-04
IL312092A (en) 2024-06-01
TW201836594A (zh) 2018-10-16
WO2018165098A1 (en) 2018-09-13
US20180256637A1 (en) 2018-09-13
IL284684B2 (en) 2023-08-01
AU2018231016B2 (en) 2024-03-07
IL268882A (en) 2019-10-31
JP2024174935A (ja) 2024-12-17
ZA202208504B (en) 2024-01-31
KR102706379B1 (ko) 2024-09-19
EP3592342B1 (en) 2024-06-19
IL284684A (en) 2021-08-31
IL268882B (en) 2021-07-29
IL312092B1 (en) 2025-04-01
IL301302A (en) 2023-05-01
US20240285677A1 (en) 2024-08-29
US20190255098A1 (en) 2019-08-22
ZA201905679B (en) 2023-02-22
CA3055105A1 (en) 2018-09-13
US11564938B2 (en) 2023-01-31
US20210077524A1 (en) 2021-03-18
EP4406595A2 (en) 2024-07-31
IL301302B2 (en) 2024-09-01
KR102760913B1 (ko) 2025-02-03
ES2986444T3 (es) 2024-11-11
ZA202307367B (en) 2024-11-27
BR112019018861A2 (pt) 2023-10-10
US20230256005A1 (en) 2023-08-17
IL301302B1 (en) 2024-05-01
IL284684B1 (en) 2023-04-01
PH12019501950A1 (en) 2020-06-15
JP2023134621A (ja) 2023-09-27
US10328099B2 (en) 2019-06-25
TW202325265A (zh) 2023-07-01
US10898512B2 (en) 2021-01-26
JP2020510014A (ja) 2020-04-02
JP7551858B2 (ja) 2024-09-17
KR20190130588A (ko) 2019-11-22
NZ756701A (en) 2022-07-01
TWI798203B (zh) 2023-04-11
KR20240038812A (ko) 2024-03-25
KR102647803B1 (ko) 2024-03-15
AU2024203535B2 (en) 2026-04-23
NZ797740A (en) 2026-02-27
EP4406595A3 (en) 2024-10-30
NZ789172A (en) 2026-02-27
KR20240137711A (ko) 2024-09-20
EP3592342A1 (en) 2020-01-15
JP7314050B2 (ja) 2023-07-25
NZ797744A (en) 2026-02-27
AU2018231016A1 (en) 2019-09-19
TWI835595B (zh) 2024-03-11
EP3592342A4 (en) 2020-12-23
IL312092B2 (en) 2025-08-01
JP7765687B2 (ja) 2025-11-07

Similar Documents

Publication Publication Date Title
AR111166A1 (es) Uso intradialítico de nitrito de sodio
ES2395369T5 (es) Soluciones basadas en bicarbonato para terapias de diálisis
HRP20240485T1 (hr) Pripravci glp-1 i njihova upotreba
MX2016015466A (es) Metodo para tratar dializado, sistema de dialisis y metodo para pre-evaluar pacientes de dialisis para el tratamiento con los mismos.
EA201071413A1 (ru) Способ и композиция для лечения повышения внутриглазного давления и глаукомы
AR070195A1 (es) Recipiente reutilizable de drenaje de efluentes para dialisis y otras terapias medicas de fluido
AR123570A1 (es) Tratamientos para el edema macular diabético y la agudeza visual disminuida
BR112015025358A2 (pt) gotejador ocular e método para administrar gotas de líquido na superfície do olho
CO6592015A2 (es) Métodos y composiciones para reducir o prevenir la cladificación vascular durante el tratamiento de diálisis peritoneal
MX2015008529A (es) Solucion para conservar conductos vasculares.
MX392901B (es) Tratamiento que comprende la administracion oral o gastrica de edaravona
PE20181332A1 (es) Metodos de sedacion y formulacion parenteral para uso durante el tratamiento de cuidados criticos
ZA202209104B (en) Intradialytic use of sodium thiosulfate
AR103415A1 (es) Tratamiento de pacientes pediátricos con diabetes mellitus de tipo 2
AR111374A1 (es) Uso de lik066 en pacientes con insuficiencia cardíaca
AR091977A1 (es) El uso de antitrombina en la oxigenacion de membranas extracorporeas
MX390948B (es) Administracion intravenosa de citrulina durante cirugia.
RU2013128357A (ru) Стабильный готовый к применению инъекционный раствор цетрореликса
MX2019014675A (es) Solucion de levodopa para infusion.
BR112017025527A2 (pt) preparação farmacêutica líquida, e, método para fabricar uma suspensão de celocoxibe.
AR067047A1 (es) Formulaciones acuosas de acetaminofen para inyeccion.
PL431139A1 (pl) Kompozycja farmaceutyczna bimatoprostu i tymololu
RU2366174C1 (ru) Способ бальзамирования трупа
AR111313A1 (es) Composición osmóticamente activa para diálisis
RU2015133365A (ru) Альфа-2 адренергический агонист для лечения внутриглазного давления и заболеваний глаз путем введения в стекловидное тело и внутрикамерно

Legal Events

Date Code Title Description
FC Refusal